2-acyl-6-(alpha-D-mannosyl-(1->4)-alpha-D-glucosaminyl)-1-(1-radyl,2-acyl-sn-glycero-3-phospho)-1D-myo-inositol zwitterion

Term ID

CHEBI:143818

Synonyms

2-acyl-6-(alpha-D-Man(1->4)-alpha-D-GlcN)-1-(1-radyl,2-acyl-sn-glycero-3-phospho)-1D-myo-inositol zwitterion
a 2-acyl-6-(alpha-D-mannosyl-(1->4)-alpha-D-glucosaminyl)-1-(1-radyl,2-acyl-sn-glycero-3-phospho)-1D-myo-inositol

Definition

A mannosylglucosaminyl-phosphatidylinositol derivative featuring an acyl group attached to position 2 of the inositol ring, and a glycerol moiety where position 1 carries an R that may be either an alkyl or an acyl group, while position 2 is substituted with an acyl group (R). The R groups have undefined chain length.

References

PMID:11226175

Ontology

ChEBI ( EBI )

Relationships

is a type of: organic molecular entity

organic molecular entity Show first 5 Terms
has_functional_parent: 2-acyl-6-alpha-D-glucosaminyl-1-(1-radyl,2-acyl-sn-glycero-3-phospho)-1D-myo-inositol zwitterion dolichyl beta-D-mannosyl phosphate(1-)

2-acyl-6-alpha-D-glucosaminyl-1-(1-radyl,2-acyl-sn-glycero-3-phospho)-1D-myo-inositol zwitterion dolichyl beta-D-mannosyl phosphate(1-) Show first 5 Terms
inverse has_functional_parent: 2-acyl-6-[2-phosphoethanolamine-alpha-D-mannosyl-(1->4)-alpha-D-glucosaminyl]-1-(1-radyl,2-acyl-sn-glycero-3-phospho)-1D-myo-inositol zwitterion 2-acyl-6-[alpha-D-mannosyl-(1->6)-alpha-D-mannosyl-(1->4)-alpha-D-glucosaminyl]-1-(1-radyl,2-acyl-sn-glycero-3-phospho)-1D-myo-inositol zwitterion

2-acyl-6-[2-phosphoethanolamine-alpha-D-mannosyl-(1->4)-alpha-D-glucosaminyl]-1-(1-radyl,2-acyl-sn-glycero-3-phospho)-1D-myo-inositol zwitterion 2-acyl-6-[alpha-D-mannosyl-(1->6)-alpha-D-mannosyl-(1->4)-alpha-D-glucosaminyl]-1-(1-radyl,2-acyl-sn-glycero-3-phospho)-1D-myo-inositol zwitterion Show first 5 Terms

Phenotype

Phenotype resulting from 2-acyl-6-(alpha-D-mannosyl-(1->4)-alpha-D-glucosaminyl)-1-(1-radyl,2-acyl-sn-glycero-3-phospho)-1D-myo-inositol zwitterion

Phenotype where environments contain 2-acyl-6-(alpha-D-mannosyl-(1->4)-alpha-D-glucosaminyl)-1-(1-radyl,2-acyl-sn-glycero-3-phospho)-1D-myo-inositol zwitterion

Phenotype modified by environments containing 2-acyl-6-(alpha-D-mannosyl-(1->4)-alpha-D-glucosaminyl)-1-(1-radyl,2-acyl-sn-glycero-3-phospho)-1D-myo-inositol zwitterion

Phenotype affecting 2-acyl-6-(alpha-D-mannosyl-(1->4)-alpha-D-glucosaminyl)-1-(1-radyl,2-acyl-sn-glycero-3-phospho)-1D-myo-inositol zwitterion

Human Disease Model